Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

The inflammatory tumor microenvironment (TME) is a complex network of cancer, immune, and stromal cells interacting through cytokines and growth factors to drive tumor growth, angiogenesis, and immune ...

The translation of nanomaterials from fundamental research to clinical applications in biomedicine faces multifaceted challenges, including concerns regarding biocompatibility and long-term toxicity, ...

More than 90% of cancer deaths in America are attributable to metastasis, when cancer spreads from its original site to other parts of the body. Researchers at the Johns Hopkins Kimmel Cancer Center ...

Over the past decade, the advent of immune checkpoint blockade (ICB) therapy has transformed cancer treatment. Unlike conventional cytotoxic and targeted therapies, immunotherapy leverages both the ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the ...